Kava Extract


Boerner, R.J., et al., 2003. Kava-Kava extract LI 150 is as effective as opipramol and buspirone in generalised anxiety disorder — an 8-week randomized, doubleblind multi-centre clinical trial in 129 out-patients. Phytomedicine, 10 Suppl 4, 38-49. PMID: 12807341


Jussofie, A., Schmiz, A. & Hiemke, C., 1994. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology, 116(4), 469-474. PMID: 7701051


Lehrl, S., 2004. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebocontrolled, double-blind clinical trial. Journal of Affective Disorders, 78(2), 101-110. PMID: 14706720


Ruze, P., 1990. Kava-induced dermopathy: a niacin deficiency? Lancet, 335(8703), 1442-1445. PMID: 1972218


Stevinson, C., Huntley, A. & Ernst, E., 2002. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety, 25(4), 251-261. PMID: 11994028

Joomla SEO powered by JoomSEF